The Journal of Pediatrics

Hatch Introduces Personalized Feature Bringing Bedtime to Those Who Can't Be There

Retrieved on: 
Thursday, April 4, 2024
Mindfulness, Friends, Entrepreneurship, Mum, Hearing, Journal, Sleep, Child, Behavior, PALO, The Journal of Pediatrics, Family, Parent, Human, Toy

PALO ALTO, Calif., April 4, 2024 /PRNewswire/ -- Hatch, a sleep wellness company that teaches the whole family better sleep habits, is launching a new premium feature for its baby and kids' Rest devices that can bring family and friends closer together, no matter the distance.

Key Points: 
  • "We know that raising a child takes a village, and when that village isn't physically present it can feel isolating," says Ann Crady Weiss, Co-Founder and CEO of Hatch.
  • "Tuck-Ins can create a meaningful, sleep-inducing bedtime routine for your little one.
  • As we celebrate our 10-year anniversary, we are excited to expand our unique feature and premium Hatch+ content offerings to benefit the whole family, and we believe Tuck-Ins is a prime example of this."
  • "Tuck-Ins by You has become a bedtime special - it's like Mum is really there reading to my kids!"

Arkansas Children's Establishes $70 Million Groundbreaking Center Focused on Opioids' Impact on Children

Retrieved on: 
Thursday, November 9, 2023
Arkansas Department of Health, Arkansas Children's Hospital, Brain, ESC, Research, Opioid, Fentanyl, NICU, Pediatrics, USDA, Substance abuse, Toxicology, Arkansas Department of Corrections, Learning, Informatics, History, Pregnancy, Journal, Map, Machine learning, Poisoning, Heroin, Health, Child, Birth, NCOR, School, Mother, Alcohol withdrawal syndrome, Social work, Hospital, The Journal of Pediatrics, Fetus, ROCK, Initiative, Face, Research institute, Pharmaceutical industry, Vaccine, Nursing, Birth control

LITTLE ROCK, Ark., Nov. 9, 2023 /PRNewswire/ -- Arkansas Attorney General Tim Griffin is awarding $50 million of opioid settlement funds to Arkansas Children's to pioneer one of the nation's most ambitious research efforts dedicated to opioids' impact on children.

Key Points: 
  • I am granting $50 million of the state's opioid settlement funds to help establish the National Center for Opioid Research & Clinical Effectiveness (NCOR) at Arkansas Children's.
  • "This research center will be the first of its kind not just in Arkansas, but in the entire country.
  • "By creating this center, we are accelerating a healthier future for the children of Arkansas.
  • Scientists will work closely with the Arkansas Children's Research Institute and Arkansas Children's Nutrition Center, one of six National Human Nutrition Centers funded through the USDA-ARS.

Smileyscope and Invincikids Partner to Expand Access to Ground Breaking Pediatric Pain Management Technologies

Retrieved on: 
Tuesday, August 29, 2023
Partnership, The Journal of Pediatrics, IV, Anxiety, App Store (iOS/iPadOS), VR, Pain, Physician, Child, Pain management, Virtual reality, Trauma, Nursing, Birth control, Pediatrics

AUSTIN, Texas, Aug. 29, 2023 /PRNewswire-PRWeb/ -- Smileyscope, a pioneering virtual reality (VR) health technology company, today announces its partnership with Invincikids, an innovation-focused pediatric non-profit organization. This strategic alliance aims to increase access to pain management technologies for underserved pediatric populations across the country.

Key Points: 
  • This strategic alliance aims to increase access to pain management technologies for underserved pediatric populations across the country.
  • This strategic alliance aims to increase access to pain management technologies for underserved pediatric populations across the country.
  • Invincikids works alongside hospitals globally to introduce a broad spectrum of immersive technologies for pain management, ranging from phone-based mobile applications to clinically validated VR hardware.
  • This partnership is poised to make Invincikids and Smileyscope leaders in the global healthcare movement to reduce unnecessary pediatric pain.

Self-Esteem of Kids with Short Stature Tied to Social Supports, Not Height

Retrieved on: 
Monday, June 12, 2023
The Journal of Pediatrics, Male, Body composition, Pfizer, CHOP, Parent, Friends, Growth hormone, Social support, Quality of life, Philadelphia, Quality, GH, Science, Journal, MD, Collection, Selection bias, Manuscript, DOI, Growth, Hospital, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Growth hormone deficiency, NIH, Caregiver, Female, Children's Hospital of Philadelphia, Nursing, Birth control, Toy, Pediatrics, Child

PHILADELPHIA, June 12, 2023 /PRNewswire/ -- Challenging the assumption that short stature negatively impacts children and adolescents' self-esteem, a new study by researchers at Children's Hospital of Philadelphia (CHOP) has found that in otherwise healthy short youth, quality of life and self-esteem are associated with coping skills and how supported they feel and not the degree of their short stature. The findings were published in The Journal of Pediatrics.

Key Points: 
  • "But our data show that self-esteem among short youth is tied to social support networks and adaptive coping strategies, not their stature.
  • However, its use has expanded to those with normal GH production who are short for their age, with the sole aim of augmenting height, based on the premise that short stature is debilitating and that height increases lead to improved quality of life.
  • First, children of taller parents may be told their short stature is temporary, given the height of the parents.
  • Short parents who view their own short stature as non-problematic may be less likely to seek care for their child's short stature, whereas short parents who are unhappy about their own height may be more inclined to express negative messaging about short stature and seek medical care for their child.

Addressing the Mental Health Crisis Facing Our Youth: Cincinnati Children's Takes a Proactive Approach

Retrieved on: 
Tuesday, May 30, 2023
Oak Ridge National Laboratory, The Journal of Pediatrics, IOP, University, Pediatrics, Doctor of Psychology, Child and adolescent psychiatry, Mental disorder, Policy, COVID-19, ECHO, MBA, Research, Multimedia, Cincinnati Children's Hospital Medical Center, See, Doctor of Philosophy, Mental, Government, Bentham Science Publishers, Social, Organization, Project Echo, Parity, Intensive outpatient program, MD, Patient, University of Cincinnati, Psychiatry, Project, Behavioral medicine, MPH, Mental health, Dietitian, Adolescence, Pharmaceutical industry, Nursing, Management, Hospital, Child, Bridge

CINCINNATI, May 30, 2023 /PRNewswire/ -- As the nation grapples with a childhood mental health crisis, leaders at Cincinnati Children's are sharing details of a years-long ongoing effort to move care further "upstream" so that more children can receive help before their problems become severe.

Key Points: 
  • "To achieve that goal, we are moving away from a primarily reactive approach to care to a much more proactive approach.
  • The new report describes four pathways the collaborators have followed to transform care, each addressing different levels of the mental health crisis.
  • Experts at Cincinnati Children's published these findings to provide a roadmap to help other pediatric centers that also are overwhelmed by the mental health crisis.
  • Meanwhile, building parity in access, quality, and reimbursement between mental and physical health care in an integrated, whole-child approach remains a critical issue to be addressed.

NIH STUDY FINDS PRENATAL SUBSTANCE EXPOSURE LINKED TO CHILD BEHAVIOR PROBLEMS

Retrieved on: 
Wednesday, May 24, 2023
Duke University, The Journal of Pediatrics, Depression, Pediatrics, Methamphetamine, Anxiety, ECHO, Research, Tobacco, Heroin, Doctor of Philosophy, Bangladesh Technical Education Board, Mother, Cocaine, Risk, Biophysical environment, Passive-aggressive behavior, Dietary supplement, Birth control

DURHAM, N.C., May 24, 2023 /PRNewswire/ -- Prenatal exposure to tobacco, alcohol, and illegal drugs may increase a child's risk of displaying certain problem behaviors in later childhood, according to new research funded by the Environmental influences on Child Health Outcomes Program (ECHO) at the National Institutes of Health.

Key Points: 
  • DURHAM, N.C., May 24, 2023 /PRNewswire/ -- Prenatal exposure to tobacco, alcohol, and illegal drugs may increase a child's risk of displaying certain problem behaviors in later childhood, according to new research funded by the Environmental influences on Child Health Outcomes Program (ECHO) at the National Institutes of Health.
  • However, ECHO researchers pointed out that not all children exposed to substances had behavioral problems.
  • "Our work shows that we may be able to identify children with certain behavioral challenges based on their mothers' prenatal substance use profiles," said Sarah Maylott, PhD of Duke University.
  • "With further research, clinicians and researchers could use these results to identify and support children at higher risk for behavior problems."

Mirum Pharmaceuticals Reports Fourth Quarter and Year-End 2022 Financial Results and Provides Business Update

Retrieved on: 
Wednesday, March 8, 2023
Biotechnology, Pharmaceutical, Health, Clinical Trials, New Drug Application, Webcast, Biliary atresia, PFIC, The Journal of Pediatrics, Growth, Spiroplasma mirum, Volixibat, Event, Itch, Sale, AASLD, IBAT, Quality of life, Patient, Shanda, European Commission, Food, Investment, Pediatrics, Primary sclerosing cholangitis, Food and Drug Administration, Alagille syndrome, Primary biliary cholangitis, Sleep, Medication, Pharmaceutical industry, Satellite navigation device, Cryptocurrency

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today reported financial results for the fourth quarter and year-end 2022 and provided a business update.

Key Points: 
  • Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today reported financial results for the fourth quarter and year-end 2022 and provided a business update.
  • Published LIVMARLI data highlighting quality of life and sleep improvements in patients with Alagille syndrome in the Journal of Pediatrics.
  • As of December 31, 2022, Mirum had cash, cash equivalents, restricted cash equivalents, and short-term investments of $251.7 million.
  • Mirum will host a conference call today, March 8, 2022, at 1:30 p.m. PT/4:30 p.m.

$39+ Billion Worldwide Family/Indoor Entertainment Centers Industry to 2031 - Rising Inclination of the Young Population Towards Mobile Gaming Drives Growth - ResearchAndMarkets.com

Retrieved on: 
Wednesday, January 25, 2023
Theme Parks, General Entertainment, Entertainment, Universe, Benchmark, Organization, Main Event Entertainment, Coronavirus, Journal, FEC, The Walt Disney Company, Create, Bowlero Corporation, Nickelodeon Universe, Family, VR, Tenpin Ltd, Main Event, Acquisition, Advertising, Toy Town Museum, Dave & Buster's, Food, Ferrari World Abu Dhabi, Bandai Namco Entertainment, Arcade, Growth, Drink, Legoland Discovery Centre, The Journal of Pediatrics, AR, Ageing, Video game, Amusement park, Marketing, Pediatrics, KidZania, Freehold

This report provides strategists, marketers and senior management with the critical information they need to assess the global family/indoor entertainment centers market.

Key Points: 
  • This report provides strategists, marketers and senior management with the critical information they need to assess the global family/indoor entertainment centers market.
  • The growing inclination of the young population towards mobile gaming is expected to propel the growth of the family or indoor entertainment centers market.
  • Family indoor entertainment centers offer mobile games with the best options for the younger people, as a result, the growing inclination toward mobile gaming increases the demand for family or indoor entertainment centers market.
  • Therefore, the growing inclination of the young population towards mobile gaming is expected to boost demand for family or indoor entertainment centers during the forecast period.

Encouraging Play Helps Parents Better Support Their Children's Development

Retrieved on: 
Tuesday, December 13, 2022
Mother, Food, New York University Grossman School of Medicine, NYU Langone Health, Child Behavior Checklist, Doctor of Philosophy, Life, Northwestern University, Book, Psychology, Human development, Education, Attention deficit hyperactivity disorder predominantly inattentive, FCU, Nuffield Department of Population Health, Parent, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Cognitive development, VIP, Medicaid, Journal, University, Reading, BA, Toddler, Depression, Population health, The Journal of Pediatrics, NYU, Toy, Tutoring, Medicine, Management, Black, Health, Culture

NEW YORK, Dec. 13, 2022 /PRNewswire/ -- Guiding parents to play and read with their babies increased parental support of their children's cognitive development by the time they turned twosetting the stage for children's improved school readiness by age four.

Key Points: 
  • NEW YORK, Dec. 13, 2022 /PRNewswire/ -- Guiding parents to play and read with their babies increased parental support of their children's cognitive development by the time they turned twosetting the stage for children's improved school readiness by age four.
  • The work evaluated the effects of a parental education and support program they developed, called Smart Beginnings, for primarily Black and Hispanic children growing up in low-income and under-resourced communities.
  • Most of the mothers were married or had a live-in partner, and all were eligible for Medicaid.
  • As the children got older, books were also given to the parents to read to the children.

Lucy Therapeutics Expands Leadership Team with Appointment of Julia Gaebler, Ph.D., as Chief Business Officer

Retrieved on: 
Tuesday, November 15, 2022
Health, Neurology, Clinical Trials, Research, Science, Pharmaceutical, Biotechnology, Journal, Graduate school, Johns Hopkins University, Partnership, Infection, Degenerative disease, Therapy, Diagnosis, Lucy, Patient, Mitochondrion, Hoffmann-La Roche, Multimedia, Paul H. Nitze School of Advanced International Studies, Economics, Frederick S. Pardee RAND Graduate School, Health policy, Biomarker, CNS, Research, Doctor of Philosophy, Metabolism, Genetics, University, Disease, M.A, Harvard University, Growth, Central nervous system, Multiple sclerosis, Rett syndrome, Drug discovery, Public health, Gaebler Children's Center, University of California, The Journal of Pediatrics, Society for Vascular Surgery, Health, Medtech, Rett, Pharmaceutical industry, Nature, Biogen, Pediatrics

Lucy Therapeutics, Inc., a private biotech company developing proprietary mitochondrial-based small molecule therapies and biomarkers for neurological diseases, today announced the appointment of business-side biopharma leader Julia Gaebler, Ph.D., as Chief Business Officer.

Key Points: 
  • Lucy Therapeutics, Inc., a private biotech company developing proprietary mitochondrial-based small molecule therapies and biomarkers for neurological diseases, today announced the appointment of business-side biopharma leader Julia Gaebler, Ph.D., as Chief Business Officer.
  • Dr. Gaebler has more than 25 years of business development and strategy experience in the life sciences industry, across biopharma, consulting, and academia.
  • View the full release here: https://www.businesswire.com/news/home/20221115005644/en/
    Dr. Gaebler will direct Lucy Therapeutics fundraising, growth and partnership activities for its promising proprietary preclinical compounds in Parkinsons disease, Rett syndrome, and other diseases of mitochondrial dysfunction.
  • Prior to joining Lucy Therapeutics, Dr. Gaebler was vice president of commercial strategy and portfolio planning at Milestone Pharmaceuticals and partner at Health Advances, a life-sciences strategy consulting firm.